SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-21-019916
Filing Date
2021-08-16
Accepted
2021-08-16 08:01:21
Documents
62
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 1718675
2 ex31-1.htm EX-31.1 18465
3 ex31-2.htm EX-31.2 18267
4 ex32-1.htm EX-32.1 9125
5 ex32-2.htm EX-32.2 9288
  Complete submission text file 0001493152-21-019916.txt   5878715

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE ensc-20210630.xsd EX-101.SCH 39071
7 XBRL CALCULATION FILE ensc-20210630_cal.xml EX-101.CAL 42722
8 XBRL DEFINITION FILE ensc-20210630_def.xml EX-101.DEF 169288
9 XBRL LABEL FILE ensc-20210630_lab.xml EX-101.LAB 331587
10 XBRL PRESENTATION FILE ensc-20210630_pre.xml EX-101.PRE 259711
11 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 757823
Mailing Address 7946 IVANHOE AVENUE SUITE 201 LA JOLLA CA 92037
Business Address 7946 IVANHOE AVENUE SUITE 201 LA JOLLA CA 92037 (858) 263-4196
Ensysce Biosciences, Inc. (Filer) CIK: 0001716947 (see all company filings)

IRS No.: 822755287 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38306 | Film No.: 211174604
SIC: 2834 Pharmaceutical Preparations